Cargando…

Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS

BACKGROUND: Quantification of kappa free light chains (KFLC) in cerebrospinal fluid shows high diagnostic sensitivity in multiple sclerosis and clinically isolated syndrome patients. However, a clearly defined threshold value is still missing and a possible prognostic value of the KFLC levels in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Presslauer, Stefan, Milosavljevic, Dejan, Huebl, Wolfgang, Parigger, Silvia, Schneider-Koch, Gabriele, Bruecke, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940961/ https://www.ncbi.nlm.nih.gov/pubmed/24651567 http://dx.doi.org/10.1371/journal.pone.0089945

Ejemplares similares

Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
por: Senel, Makbule, et al.
Publicado: (2014)

Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS
por: Duell, Frida, et al.
Publicado: (2020)

Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity
por: Berek, Klaus, et al.
Publicado: (2021)

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study
por: Leurs, CE, et al.
Publicado: (2019)

Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity—a cohort study
por: Hegen, Harald, et al.
Publicado: (2023)

Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy
por: Kleeberg, L, et al.
Publicado: (2009)

Intrathecal kappa free light chains as markers for multiple sclerosis
por: Vecchio, D., et al.
Publicado: (2020)

The Use of Kappa Free Light Chains to Diagnose Multiple Sclerosis
por: Arneth, Borros, et al.
Publicado: (2022)

The Impact of Immunomodulatory Treatment on Kappa Free Light Chains as Biomarker in Neuroinflammation
por: Konen, Franz Felix, et al.
Publicado: (2020)

The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2021)

Is CSF neurofilament light chain measurement relevant for MS?
por: Matsui, Makoto
Publicado: (2020)

Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies
por: Lee, Won Sok, et al.
Publicado: (2018)

Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy
por: Süße, Marie, et al.
Publicado: (2020)

The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid
por: Konen, Franz F, et al.
Publicado: (2021)

Kappa light-chain amyloidosis of gastrointestinal tract
por: Hashimoto, Rintaro, et al.
Publicado: (2019)

Reiber’s Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases
por: Konen, Franz Felix, et al.
Publicado: (2022)

Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements
por: Natali, Patrizia, et al.
Publicado: (2022)

Kappa free light chains index in multiple sclerosis very long-term prognosis
por: Arroyo-Pereiro, Pablo, et al.
Publicado: (2023)

A case of light chain deposition disease involving the kidney with a normal serum free kappa/lambda light chain ratio
por: Zhang, Suojian, et al.
Publicado: (2022)

Atypical Nodular Pulmonary Kappa Light-Chain Deposition
por: Nellipudi, Jessy, et al.
Publicado: (2021)

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
por: Hegen, Harald, et al.
Publicado: (2022)

Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes
por: Levraut, Michael, et al.
Publicado: (2023)

The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2018)

Free kappa light chains in cerebrospinal fluid as a biomarker to assess risk conversion to multiple sclerosis
por: Menéndez-Valladares, P, et al.
Publicado: (2015)

Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis
por: Gudowska-Sawczuk, Monika, et al.
Publicado: (2020)

A New Laboratory Workflow Integrating the Free Light Chains Kappa Quotient into Routine CSF Analysis
por: Hannich, Malte Johannes, et al.
Publicado: (2022)

The role of intrathecal free light chains kappa for the detection of autoimmune encephalitis in subacute onset neuropsychiatric syndromes
por: Bertram, Dominic, et al.
Publicado: (2023)

Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2023)

Evidence for an Intrathecal Immunoglobulin Synthesis by Kappa Free Light Chains in Neurological Patients with an Isolated Band in Isoelectric Focusing
por: Weiss, Bastian, et al.
Publicado: (2022)

Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
por: Hegen, Harald, et al.
Publicado: (2022)

High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
por: Rosenstein, Igal, et al.
Publicado: (2023)

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis
por: Hegen, Harald, et al.
Publicado: (2022)

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study
por: Levraut, Michael, et al.
Publicado: (2022)

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
por: Monreal, Enric, et al.
Publicado: (2023)

Evaluation of CSF kappa free light chains for the diagnosis of multiple sclerosis (MS): a comparison with oligoclonal bands (OCB) detection via isoelectric focusing (IEF) coupled with immunoblotting
por: Abid, Muhammad Abbas, et al.
Publicado: (2023)

A murine hybridoma with large cytoplasmic inclusions of kappa light chains
Publicado: (1987)

Triphenotypic multiple myeloma expressing kappa or lambda light chain or both
por: Liu, Yang, et al.
Publicado: (2013)

Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co-Expression
por: Ahn, Yong Hwan, et al.
Publicado: (2018)

Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab
por: Tariq, Hamza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8b58nnf7p6mj66ogdcvjh6a5us